Transcriptome Remodeling Contributes to Epidemic Disease Caused by the Human Pathogen <named-content content-type="genus-species">Streptococcus pyogenes</named-content>
Stephen B. Beres,
Priyanka Kachroo,
Waleed Nasser,
Randall J. Olsen,
Luchang Zhu,
Anthony R. Flores,
Ivan de la Riva,
Jesus Paez-Mayorga,
Francisco E. Jimenez,
Concepcion Cantu,
Jaana Vuopio,
Jari Jalava,
Karl G. Kristinsson,
Magnus Gottfredsson,
Jukka Corander,
Nahuel Fittipaldi,
Maria Chiara Di Luca,
Dezemona Petrelli,
Luca A. Vitali,
Annessa Raiford,
Leslie Jenkins,
James M. Musser
Affiliations
Stephen B. Beres
Center for Molecular and Translational Human Infectious Diseases Research, Department of Pathology and Genomic Medicine, Houston Methodist Research Institute, and Houston Methodist Hospital, Houston, Texas, USA
Priyanka Kachroo
Center for Molecular and Translational Human Infectious Diseases Research, Department of Pathology and Genomic Medicine, Houston Methodist Research Institute, and Houston Methodist Hospital, Houston, Texas, USA
Waleed Nasser
Center for Molecular and Translational Human Infectious Diseases Research, Department of Pathology and Genomic Medicine, Houston Methodist Research Institute, and Houston Methodist Hospital, Houston, Texas, USA
Randall J. Olsen
Center for Molecular and Translational Human Infectious Diseases Research, Department of Pathology and Genomic Medicine, Houston Methodist Research Institute, and Houston Methodist Hospital, Houston, Texas, USA
Luchang Zhu
Center for Molecular and Translational Human Infectious Diseases Research, Department of Pathology and Genomic Medicine, Houston Methodist Research Institute, and Houston Methodist Hospital, Houston, Texas, USA
Anthony R. Flores
Center for Molecular and Translational Human Infectious Diseases Research, Department of Pathology and Genomic Medicine, Houston Methodist Research Institute, and Houston Methodist Hospital, Houston, Texas, USA
Ivan de la Riva
Center for Molecular and Translational Human Infectious Diseases Research, Department of Pathology and Genomic Medicine, Houston Methodist Research Institute, and Houston Methodist Hospital, Houston, Texas, USA
Jesus Paez-Mayorga
Center for Molecular and Translational Human Infectious Diseases Research, Department of Pathology and Genomic Medicine, Houston Methodist Research Institute, and Houston Methodist Hospital, Houston, Texas, USA
Francisco E. Jimenez
Center for Molecular and Translational Human Infectious Diseases Research, Department of Pathology and Genomic Medicine, Houston Methodist Research Institute, and Houston Methodist Hospital, Houston, Texas, USA
Concepcion Cantu
Center for Molecular and Translational Human Infectious Diseases Research, Department of Pathology and Genomic Medicine, Houston Methodist Research Institute, and Houston Methodist Hospital, Houston, Texas, USA
Jaana Vuopio
Department of Medical Microbiology and Immunology, Medical Faculty, University of Turku, Turku, Finland
Jari Jalava
Department of Infectious Diseases, National Institute for Health and Welfare, Turku, Finland
Karl G. Kristinsson
Departments of Clinical Microbiology and Infectious Diseases, Landspitali University Hospital, Reykjavik, Iceland
Magnus Gottfredsson
Departments of Clinical Microbiology and Infectious Diseases, Landspitali University Hospital, Reykjavik, Iceland
Jukka Corander
Department of Biostatistics, University of Oslo, Oslo, Norway, and Department of Mathematics and Statistics, University of Helsinki, Helsinki, Finland
Nahuel Fittipaldi
Public Health Ontario, and Department of Laboratory Medicine and Pathobiology, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada
Maria Chiara Di Luca
School of Pharmacy, University of Camerino, Camerino, Italy
Dezemona Petrelli
School of Biosciences and Veterinary Medicine, University of Camerino, Camerino, Italy
Luca A. Vitali
School of Pharmacy, University of Camerino, Camerino, Italy
Annessa Raiford
Comparative Medicine Program, Houston Methodist Research Institute, Houston, Texas, USA
Leslie Jenkins
Comparative Medicine Program, Houston Methodist Research Institute, Houston, Texas, USA
James M. Musser
Center for Molecular and Translational Human Infectious Diseases Research, Department of Pathology and Genomic Medicine, Houston Methodist Research Institute, and Houston Methodist Hospital, Houston, Texas, USA
ABSTRACT For over a century, a fundamental objective in infection biology research has been to understand the molecular processes contributing to the origin and perpetuation of epidemics. Divergent hypotheses have emerged concerning the extent to which environmental events or pathogen evolution dominates in these processes. Remarkably few studies bear on this important issue. Based on population pathogenomic analysis of 1,200 Streptococcus pyogenes type emm89 infection isolates, we report that a series of horizontal gene transfer events produced a new pathogenic genotype with increased ability to cause infection, leading to an epidemic wave of disease on at least two continents. In the aggregate, these and other genetic changes substantially remodeled the transcriptomes of the evolved progeny, causing extensive differential expression of virulence genes and altered pathogen-host interaction, including enhanced immune evasion. Our findings delineate the precise molecular genetic changes that occurred and enhance our understanding of the evolutionary processes that contribute to the emergence and persistence of epidemically successful pathogen clones. The data have significant implications for understanding bacterial epidemics and for translational research efforts to blunt their detrimental effects. IMPORTANCE The confluence of studies of molecular events underlying pathogen strain emergence, evolutionary genetic processes mediating altered virulence, and epidemics is in its infancy. Although understanding these events is necessary to develop new or improved strategies to protect health, surprisingly few studies have addressed this issue, in particular, at the comprehensive population genomic level. Herein we establish that substantial remodeling of the transcriptome of the human-specific pathogen Streptococcus pyogenes by horizontal gene flow and other evolutionary genetic changes is a central factor in precipitating and perpetuating epidemic disease. The data unambiguously show that the key outcome of these molecular events is evolution of a new, more virulent pathogenic genotype. Our findings provide new understanding of epidemic disease.